Contaminated Blood Products Public Inquiry;amdt. Line 4:

EDM number 1816A1 in 2003-04, proposed by Michael Connarty on 04/11/2004.

Line 4, leave out from 'inquiry' to end and insert 'into the use of contaminated blood products in the treatment of haemophilia and in transfusions in the past; while recognising the progress made in the term of the present Labour government in allocating funds to provide non blood based recombinant clotting products for throughout the UK and a fund of approximately ú100 million to provide payments to all who are living with Hepatitis C, and urge the government to extend the payments to the families of those who have died as a result of contaminated blood products.'

This is a ammendment to 1816.

This motion has been signed by a total of 12 MPs.